Cargando…

Identification of neoantigens and immunological subtypes in clear cell renal cell carcinoma for mRNA vaccine development and patient selection

Clear cell renal cell carcinoma (ccRCC) is a common urological malignancy with diverse histological types. This study aimed to detect neoantigens in ccRCC to develop mRNA vaccines and distinguish between ccRCC immunological subtypes for construction of an immune landscape to select patients suitable...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Daoqi, Yang, Jiabin, Zhang, Minyi, Han, Zhongxiao, Shao, Meng, Fan, Qin, Ma, Yun, Xie, Dandan, Xiao, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292886/ https://www.ncbi.nlm.nih.gov/pubmed/37315301 http://dx.doi.org/10.18632/aging.204798

Ejemplares similares

Identification of IRF-associated molecular subtypes in clear cell renal cell carcinoma to characterize immunological characteristics and guide therapy
por: Chen, Can, et al.
Publicado: (2023)

Tumor antigens and immune subtypes guided mRNA vaccine development for kidney renal clear cell carcinoma
por: Xu, Hang, et al.
Publicado: (2021)

Systematic Chromatin Accessibility Analysis Based on Different Immunological Subtypes of Clear Cell Renal Cell Carcinoma
por: Zhang, Shiqiang, et al.
Publicado: (2021)

MicroRNA expression profiles in molecular subtypes of clear-cell renal cell carcinoma are associated with clinical outcome and repression of specific mRNA targets
por: Verbiest, Annelies, et al.
Publicado: (2020)

Prognostic value and immunological role of AXL gene in clear cell renal cell carcinoma associated with identifying LncRNA/RBP/AXL mRNA networks
por: Wang, Yi, et al.
Publicado: (2021)

Immunological perspective on the malignant progression of renal clear cell carcinoma
por: Liu, Ji, et al.
Publicado: (2021)

Circulating exosomal mRNA signatures for the early diagnosis of clear cell renal cell carcinoma
por: He, Xing, et al.
Publicado: (2022)

Prognostic value of JAK3 promoter methylation and mRNA expression in clear cell renal cell carcinoma
por: Long, Qian, et al.
Publicado: (2021)

Molecular subtyping and characterization of clear cell renal cell carcinoma by tumor differentiation trajectories
por: Pan, Xiu-wu, et al.
Publicado: (2023)

Identification of Neoantigens and Construction of Immune Subtypes in Prostate Adenocarcinoma
por: Gao, Yukui, et al.
Publicado: (2022)

Molecular and Metabolic Subtypes in Sporadic and Inherited Clear Cell Renal Cell Carcinoma
por: Czyzyk-Krzeska, Maria F., et al.
Publicado: (2021)

Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma
por: Liu, Huiqing, et al.
Publicado: (2010)

High PRAS40 mRNA expression and its role in prognosis of clear cell renal cell carcinoma
por: Zhou, Jintuo, et al.
Publicado: (2020)

Characterizing the Immune Microenvironment and Neoantigen Landscape of Hürthle Cell Carcinoma to Identify Potential Immunologic Vulnerabilities
por: Ganly, Ian, et al.
Publicado: (2023)

APOA1 mRNA and protein in kidney renal clear cell carcinoma correlate with the disease outcome
por: Zeng, Wei, et al.
Publicado: (2022)

Radiomic profiling of clear cell renal cell carcinoma reveals subtypes with distinct prognoses and molecular pathways
por: Lin, Peng, et al.
Publicado: (2021)

m7G regulator-mediated molecular subtypes and tumor microenvironment in kidney renal clear cell carcinoma
por: Chen, Mei, et al.
Publicado: (2022)

Identification of tumor-specific neoantigens and immune clusters of hepatocellular carcinoma for mRNA vaccine development
por: Li, Yi-Fei, et al.
Publicado: (2022)

Determination of Angptl4 mRNA as a Diagnostic Marker of Primary and Metastatic Clear Cell Renal-Cell Carcinoma
por: Verine, Jérôme, et al.
Publicado: (2010)

Molecular subtypes of m(6)A RNA methylation modification patterns and their clinical significance in clear cell renal cell carcinoma
por: Guan, Bo, et al.
Publicado: (2022)

Identification of Immune-Related Subtypes and Characterization of Tumor Microenvironment Infiltration in Kidney Renal Clear Cell Carcinoma
por: Qin, Huisheng, et al.
Publicado: (2022)

Angiogenesis-Related Molecular Subtypes and a Novel Prognostic Signature in Clear Cell Renal Cell Carcinoma Patients
por: Li, Hao, et al.
Publicado: (2021)

Prognostic and immunological significance of calcium-related gene signatures in renal clear cell carcinoma
por: Liu, An, et al.
Publicado: (2022)

Immune subtypes and neoantigen-related immune evasion in advanced colorectal cancer
por: Sugawara, Toshitaka, et al.
Publicado: (2022)

Identification of novel differentially expressed lncRNA and mRNA transcripts in clear cell renal cell carcinoma by expression profiling
por: Deng, Mario, et al.
Publicado: (2015)

The mRNA Expression Signature and Prognostic Analysis of Multiple Fatty Acid Metabolic Enzymes in Clear Cell Renal Cell Carcinoma
por: Zhao, Zuohui, et al.
Publicado: (2019)

Patterns of gene expression characterize T1 and T3 clear cell renal cell carcinoma subtypes
por: Borys, Agnieszka M., et al.
Publicado: (2019)

Identification and Verification of Immune Subtype-Related lncRNAs in Clear Cell Renal Cell Carcinoma
por: Wang, Zhifeng, et al.
Publicado: (2022)

Identification of immune subtypes to guide immunotherapy and targeted therapy in clear cell renal cell carcinoma
por: Xu, Chen, et al.
Publicado: (2022)

The core genes of cuproptosis assists in discerning prognostic and immunological traits of clear cell renal cell carcinoma
por: Chu, Binxiang, et al.
Publicado: (2022)

Curcumin Enhances Radiosensitization of Nasopharyngeal Carcinoma via Mediating Regulation of Tumor Stem-like Cells by a CircRNA Network
por: Zhu, Daoqi, et al.
Publicado: (2020)

Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma
por: Wu, Peng, et al.
Publicado: (2018)

Identification of anoikis-related subtypes and immune landscape in kidney renal clear cell carcinoma
por: Ding, Wencong, et al.
Publicado: (2023)

Immunological analysis of hybrid neoantigen peptide encompassing class I/II neoepitope-pulsed dendritic cell vaccine
por: Morisaki, Shinji, et al.
Publicado: (2023)

Crosstalk Between Metabolism and Immune Activity Reveals Four Subtypes With Therapeutic Implications in Clear Cell Renal Cell Carcinoma
por: Wang, Yi, et al.
Publicado: (2022)

Integrative analysis of protein-coding and non-coding RNAs identifies clinically relevant subtypes of clear cell renal cell carcinoma
por: Li, Zongcheng, et al.
Publicado: (2016)

Construct a circRNA/miRNA/mRNA regulatory network to explore potential pathogenesis and therapy options of clear cell renal cell carcinoma
por: Bai, Shuheng, et al.
Publicado: (2020)

Exploring the miRNA-mRNA Regulatory Network in Clear Cell Renal Cell Carcinomas by Next-Generation Sequencing Expression Profiles
por: Müller, Sören, et al.
Publicado: (2014)

Epithelial-mesenchymal transition-associated microRNA/mRNA signature is linked to metastasis and prognosis in clear-cell renal cell carcinoma
por: Mlcochova, Hana, et al.
Publicado: (2016)

Decreased expression of SLC16A12 mRNA predicts poor prognosis of patients with clear cell renal cell carcinoma
por: Mei, Jie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3p0bvhhuabmj91fho1f8ovhv4r